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A highly eﬃcient catalytic enantioselective [4+2] cycloaddition was developed between 2-
benzothiazolimines and enecarbamates. A wide range of benzothiazolopyrimidines bearing three
contiguous stereogenic centers was obtained in high to excellent yields and with excellent diastereo-
and enantioselectivities (d.r. > 98 : 2 and up to >99% ee). Furthermore, this chiral phosphoric acid-
catalyzed strategy was scalable and enabled access to a new class of optically pure Lewis base
isothiourea derivatives.Introduction
Isothioureas constitute an important class of organocatalysts
due to their highly nucleophilic nature.1 Recent eﬀorts have
been directed to the development of chiral derivatives capable
of promoting enantioselective transformations, which are
diﬃcult to control using traditional nucleophilic catalysts.
Among the several promising examples, benzothiazolopyr-
imidine, better known as homobenzotetramisole (HBTM), has
assumed a leading position as a chiral catalyst. Chiral HBTMs
have been successfully used in a number of asymmetric trans-
formations1a including the kinetic resolution of secondary
alcohols and carboxylic acids,2 desymmetrization,3 acyl trans-
fer,4 annulation processes,5 and lactonisation,6 among others.7
Nevertheless, despite the interest in optically active HBTMs,1a
there have been only limited reports on their enantioselective
synthesis.8 In 2008, Birman et al. disclosed the rst asymmetric
synthesis of HBTMs following a seven-step sequence involving
a key SNAr reaction between 2-chlorobenzo[d]thiazole and
amino-alcohols prepared from the chiral pool of amino acids
(Scheme 1a).2f Chiral amino-alcohols, produced by catalytic
enantioselective procedures, were later engaged in similar
routes as reported by the same group as well as by Smith et al.
and Okamoto et al. (Scheme 1a).4a,b,9 More recently, Enders et al.s, CNRS UPR 2301, Universite´ Paris-Sud,
asse, 91198 Gif-sur-Yvette Cedex, France.
ic Chemistry and Biochemistry, Bijenicˇka
lte´ de Pharmacie Biocis 8076, LabEx
ay Malabry, France
(ESI) available. CCDC 1815484 and
a in CIF or other electronic format see
hemistry 2019established an eﬃcient asymmetric synthesis of precursors of
HBTMs by the N-heterocyclic carbene-catalyzed Mannich/lac-
tamization domino reaction of 2-benzothiazolimines and a-
chloroaldehydes (Scheme 1b).10 Despite these examples, no
catalytic asymmetric approach has been reported so far to
directly construct these heterocycles. An attractive direct access
relying on the aza-Diels–Alder approach has been reported by
Mellor et al. for the synthesis of homobenzotetramisole in an
achiral stoichiometric context.9,11 The requirement of a full
equivalent of the acid to perform the reaction is self-evident due
to the presence of the basic isothiourea that might capture the
acid during the formation of HBTMs.2f,12 Turning this process
into a catalytic enantioselective approach would be highlyScheme 1 Previous studies and our strategy.
Chem. Sci., 2019, 10, 3765–3769 | 3765
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View Article Onlineappealing, not only to access new potent chiral Lewis bases but
also for the generation of novel biologically active molecules.13
In the past few years, chiral phosphoric acids have been
widely recognized as powerful catalysts for the synthesis of
various heterocycles containing nitrogen atoms.14 In this context,
we have recently documented phosphoric acid-catalyzed enan-
tioselective aza-Diels–Alder reactions14,15 of various azadienes
with enecarbamates as dienophiles.16 Based on these studies, we
envisioned that this Brønsted acid 1may be capable of promoting
the [4+2] cycloaddition between 2-benzothiazolimines 2 and
enecarbamates 3 (Scheme 1c) allowing the development of an
enantioselective synthesis of benzothiazolopyrimidines 4.
Because of the formation of the basic isothiourea during the
process, catalyst poisoning might lead to diﬃculties in devel-
oping a catalytic version. Nevertheless, we reasoned that tuning
the catalyst or using additives to induce a hydrogen shuttle
could help in overcoming the problem.17
Results and discussion
With this proposal in mind, we examined the aza-Diels–Alder
reaction of 2-benzothiazolimine18 2a with (E)-N-benzyl prope-
nylcarbamate (3a) in the presence of chiral phosphoric acids 1.
Gratifyingly, in dichloromethane at room temperature, the
reaction promoted by 1a aﬀorded benzothiazolopyrimidine 4a
as a single diastereomer, with an enantiomeric excess of 95%
albeit with a low yield (Table 1, entry 1). Obviously, while yields
remained low, we were delighted to observe that no full catalyst
inhibition was occurring. Encouraged by this result, we
screened various reaction conditions to search for the optimal
reaction conditions. Performing the reaction at 50 C in DCETable 1 Optimization of the enantioselective [4+2] cycloadditiona
Entry Ar
T
(C) Solvent Yieldb (%) eec (%)
1d Ph (1a) RT DCM 40 95
2 1a 50 DCE 41 80
2 9-Phenantryl (1b) 50 DCE 29 85
4 2,4,6-TRIP (1c) 50 DCE 62 98
5e 1c 50 DCE 90 (68)f 99
a Reaction conditions: 2a (0.10 mmol), 3a (0.20 mmol) and 1 (0.01
mmol) in 1.0 mL of solvent for 16 h. b Yields refer to the
chromatographically pure diastereomer 4a determined to be higher
than 98 : 2 by 1H NMR. c ee values were determined by HPLC with
a chiral stationary phase. d For 24 h. e With 3 equiv. of 3a. f With 5
mol% of 1c.
3766 | Chem. Sci., 2019, 10, 3765–3769slightly improved the kinetics (16 h instead of 24 h) even if
overall yields were not superior and signicant erosion of
enantioselectivity was observed.19 Then, a series of phosphoric
acids were screened in DCE at 50 C (entries 2–4), and we found
that the catalyst structure had a marked impact on the reaction
eﬃciency. For instance, the use of chiral phosphoric acid 1c
having two bulky 3,30-(2,4,6-triisopropylphenyl) groups
improved the yield, presumably by facilitating the catalyst
turnover. A further survey of reaction conditions revealed that
the optimal conditions consisted in performing the reaction
with 3 equivalents of 3a in the presence of 10 mol% of 1c,
delivering 4a in 90% yield with almost perfect diastereo- and
enantioselectivity (entry 5).
With optimized reaction conditions in hand, the scope of
this chiral phosphoric acid-catalyzed enantioselective aza-Diels-
Alder reaction was investigated and the results are summarized
in Scheme 2. First, 2-benzothiazolimines bearing various
substituents on the aromatic rings were evaluated. Pleasingly,
the reaction was insensitive to the electronic nature of the
substituents on the benzothiazole rings. For instance, the
benzothiazole bearing either electron-donating or electron-
withdrawing groups, such as methyl, halogen and tri-
uoromethyl groups, provided the corresponding benzothia-
zolopyrimidine 4b–f in high yields and excellent
enantioselectivities (up to 99% ee). An unsubstituted benzo-
thiazole ring proceeded uneventfully to give cycloadduct 4g with
almost perfect enantioselectivity (up to 99% ee). It is worth
noting that the reactions performed on a 1 mmol scale dis-
played the same results as the ones on a 0.10 mmol scale,
further indicating the practicality of this protocol. On the other
hand, the electronic properties of aromatic rings that came
from aldehydes had no signicant impact on the enantiomeric
excess, though the reaction with the electron-rich imine gave
a slightly lower yield (4h vs. 4a). When the reaction was con-
ducted with imine, which had bromine at themeta-position, the
desired cycloadduct 4k was obtained in 80% yield and 98% ee.
Notably, 4k can be enriched to >99% ee by single recrystalliza-
tion, which is very interesting in view of their use as organo-
catalysts. Moreover, a relative and absolute conguration was
unambiguously determined by single crystal X-ray analysis (see
the ESI†). Finally, the reaction with imine 2l derived from 2-
thiophenecarboxaldehyde proceeded smoothly to give the
cycloadduct 4l in almost quantitative yields with 98% ee. This
novel catalytic enantioselective cycloaddition was also applied
to representative enecarbamates (Scheme 2). Notably, a variety
of protecting groups bonded to the nitrogen atom of 3
(including Boc, Alloc and 4-(triuoromethyl)benzylcarbamate)
were well tolerated and the corresponding benzothiazolopyr-
imidines (4m–q) were, in all cases, isolated in excellent yields
and excellent stereoselectivities. It is noteworthy that the cata-
lyst loading was successfully reduced to 5.0 mol% (4q, entry 10).
A comparable enantioselectivity (97%) was still achieved with
a slightly lower chemical yield (70%).
In addition, b-substituted enecarbamates bearing diﬀerent
alkyl groups reacted eﬃciently to deliver expected trisubsti-
tuted-cycloadducts 4r–u in good to excellent yields with high
selectivities (94 to 98% ee). The reaction with 3c or 3dThis journal is © The Royal Society of Chemistry 2019
Scheme 2 Scope of the enantioselective synthesis of benzothiazo-
lopyrimidines 4. a General reaction conditions: 2 (0.1 mmol), 3 (0.3
mmol), 1c (10 mol%), 1,2-DCE (1 mL, 0.1 M), 50 C, and 24 h. Yields
refer to chromatographically puriﬁed compounds. The d.r. values were
determined by 1H NMR analysis to be higher than 98 : 2 in all cases.
The ee values were determined by HPLC on a chiral stationary phase:
see the ESI† for details. a From 1.0 mmol of 2g. b After recrystallization.
c From 0.3 mmol of 2b. d With 5 mol% of 1c.
Fig. 1 (A) Most stable cis and trans conformers of 4g found at the
B3LYP/6-31G(d) level. (B) Structure of intermediate 5 obtained in the
presence of 3.0 equiv. of ethanol on the way to 4k.
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
7 
Fe
br
ua
ry
 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
0/
22
/2
01
9 
8:
08
:1
6 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinecontaining a cyclopropyl or silyl ether group formed products 4s
or 4t with a slight decrease in the yield without aﬀecting
asymmetric induction.This journal is © The Royal Society of Chemistry 2019The stereoselective issue of the reaction ((E)-enecarbamates
to the cis product) raises questions about the mechanism. In
order to get insight, we computationally evaluated the free
energy of both diastereoisomers of the product 4g (Fig. 1A). The
trans form was found favoured by more than 5.2 kcal mol1 over
its cis sibling (see the ESI†). This result together with the fact
that the cis isomer is actually observed suggests that the cyclo-
addition occurs under kinetic control. A stepwise process was
established by performing a control experiment in the presence
of 3 equivalents of ethanol, which evidenced the formation of
an N-Cbz-iminium intermediate (5, Fig. 1B).
Based on this, as well as our previous work and other pub-
lished reports,14,16,20 a possible catalytic mechanism was
proposed in Scheme 3. We hypothesized that 1 would form
a hydrogen network with the nitrogen Lewis basic sites of 2-
benzothiazolimine 2 and the acidic site of enecarbamate 3,
leading to complex 6. Mediated by the phosphoric acid double
activation, subsequent bond formation would deliver complex
7. The aromatic and R residue would be positioned in a trans
situation as found in the product, but the pseudo equatorial
arrangement would create substantial strain. Maintained in the
chiral cavity by the double hydrogen anchors, rotation of the
backbone would furnish a sterically less-congested conformer 8.
Finally the intramolecular nucleophilic addition of benzothia-
zole to iminium will give the observed cis–trans substitutedScheme 3 Plausible mechanism and transition states.
Chem. Sci., 2019, 10, 3765–3769 | 3767
Scheme 4 Derivatization of the benzothiazolopyrimidine product 4q.
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View Article Onlinebenzothiazolopyrimidine 4.21 Heating, rapid formation of
hydrogen-bonded complex 6 or use of excess 3may all facilitate
the decomplexation of 9 and ensure the catalyst turnover.
As a further illustration of the utility of this novel catalytic
cycloaddition, we developed conditions to convert the carba-
mate group into other functional groups. The N-Boc group of 4q
was removed by mild acidic hydrolysis to produce free alcohol
10 (a key intermediate to install additional molecular diversity)
with no erosion of enantiopurity (Scheme 4). The absolute
conguration was conrmed without ambiguity by X-ray
diﬀraction analysis (see the ESI†).
Conclusions
We have developed an eﬃcient enantioselective [4+2] cycload-
dition organocatalyzed by chiral phosphoric-acid for the
synthesis of benzothiazolopyrimidines bearing three contig-
uous stereogenic centers, which were unreported before.
Involving 2-benzothioazolimines and enecarbamates as
substrates, this scalable strategy furnished a wide range of
compounds with very high yields and enantioselectivity in
a diastereospecic manner. The obtained cycloadducts were
successfully converted into corresponding free alcohol hetero-
cycles without any loss of enantioselectivity. Further investiga-
tions are in progress concerning the catalytic activity of these
new compounds as chiral nucleophilic organocatalysts.
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